GoingToMeet

Increasing national healthcare budgetary pressures, are forcing manufacturers to think out of the box and implement more innovative reimbursement models and value-based schemes. Demonstrating product value with data that really counts in payers', regulators' and other stakeholders' decision-making processes, is essential in order to gain and retain access in key markets. Budgetary pressures however, could also present an opportunity to the medical devices industry. Many payers are considering, now more then ever, to allocate more funds towards surgical interventions involving devices instead of long-term drug treatments. Market access experts must be able to demonstrate value real evidence-based data for the long-term in order to convince payers that choosing drug therapies may actually cost them more.